MAPT and Alzheimer disease: The AD continuum stages include the preclinical stage, where the participants are cognitively unimpaired (with or without amyloid or tau biomarkers); the prodromal stage includes the early symptomatic phenotype (e.g., MCI), and the AD dementia stage refers to the phase where severe cognitive symptoms are present which affect social and daily activities [19].